A short historical review of SCNP with special reference to the UKU

Acta Neuropsychiatrica

Volumn 26, Issue 1, 2014, Pages 4-7

  Bech, Per ^a   Ban, Thomas A ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

clinical methodology; committee for clinical investigators; psychotropic drug development; SCNP; standardisation of clinical trials; UKU.

Indexed keywords

AWARDS AND PRIZES; FOOD AND DRUG ADMINISTRATION; GERMANY; HISTORY; HUMAN; LIFE EVENT; MEDICAL SCHOOL; PROFESSIONAL STANDARD; PSYCHOPHARMACOLOGY; REVIEW; CENTRAL NERVOUS SYSTEM; DRUG INDUSTRY; FUNDING; GOVERNMENT; HISTORY OF MEDICINE; MEDICAL SOCIETY; METHODOLOGY; STANDARDIZATION; ADVISORY COMMITTEE; CLINICAL TRIAL (TOPIC); HEALTH CARE ORGANIZATION; NEUROPHARMACOLOGY; STANDARDS;

PSYCHOTROPIC AGENT;

ADVISORY COMMITTEES; CLINICAL TRIALS AS TOPIC; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NEUROPHARMACOLOGY; PSYCHOPHARMACOLOGY; SOCIETIES, SCIENTIFIC;

EID: 84893781013     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1017/neu.2013.54     Document Type: Review

References (16)

1. RAVN J. First Scandinavian psychopharmacological meeting. Nordic J Psychiatry 1961;15:1-2.
2. RAVN J. Second Scandinavian psychopharmacological meeting. Nord J Psychiatry 1962;16:1-3.
3. LINGJAERDE O. Standardized instruments used in the assessment of depression in Scandinavian countries. In: Sartorius N, Ban TA, editors. Assessment of Depression. Berlin: Springer, 1986, p. 30-35.
4. LINGJAERDE O, EDLUND AH, GORMSEN CA et al. The effects of lithium carbonate in combination with tricyclic antidepressants in endogenous depression. A double-blind, multicenter trial. Acta Psychiatr Scand 1974;50:233-242.
5. BECH P, AHLFORS UG, DENCKER SJ, ELGEN K, LINGJAERDE O. The UKU side effects scale-a scale for the registration of unwanted effects of psychotropics (UKU's bivirkningsskala-skala til registrering af uønskede virkninger af psykofarmaka). Nord J Psychiatry 1986;40:147-158.
6. LINGJAERDE O, AHLFORS UG, BECH P, DENCKER SJ, ELGEN K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987;334:1-100.
7. BECH P, MALT UF, DENCKER SJ et al. Scales for Assessment of Diagnosis and Severity of Mental Disorders. Acta Psychiatrica Scand 1993;87(Suppl. 372):1-87.
8. BECH P, TRIMBLE MR, GASTPAR M et al. The current scope of psychopharmacological research in Europe. Nord J Psychiatry 1984;38(Suppl. 10):33-48.
9. HEALY D. Drugs & industry. In: Ban TA, Healy D, Shorter E, editors. The Rise of Psychopharmacology & the Story of the CINP. Budapest: Animula, 1998, p. 51-55.
10. BECH P. Issues of concern in the standardization and harmonization of psychotropic drug trials in Europe. Eur Psychiatry 1994;9:113-114.
11. STRÖ MGREN E. Current status of psychiatric research in Denmark. Psychiatrie & Psychobiologie 1987;11: 128-133.
12. FINK M. A clinician-researcher and ECDEU 1959-1980. In: Ban TA, Healy D, Shorter E, editors. The Triumph of Psychopharmacology the Story of CINP. Budapest: Animula, 2000, p. 82-92.
13. KRAMER PD. Against Depression. New York: Viking Penguin, 2005.
14. BECH P, GEX-FABRY M, AUBRY JM, FAVRE S, BERTSCHY G. Olanzapine plasma level in relation to antimanic effect in the acute therapy of manic states. Nord J Psychiatry 2006;60:181-182.
15. CARLSSON A, WONG DT. Correction: a note on the discovery of selective serotonin reuptake inhibitors. Life Sci 1997;61:1203.
16. WEGENER G, RUJESCU D. The current development of CNS drug research. Int J Neuropsychopharmacol 2013;16: 1687-1693.